NYSE · CIK 0001668717
BUD Anheuser-Busch InBev SA/NV
Insider trading from SEC Form 4. Last filing not yet seen.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
0
with a Form 4 at this company
Signals
Open-market buys and sells at Anheuser-Busch InBev SA/NV, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Congressional trades
8 trades in BUD disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Kevin Hern House · R-OK | Sale | BUD Anheuser-Busch Inbev SA Sponsored ADR | $1,001 to $15k | Aug 18, 2026 | 14 days after the trade |
| Alan Armstrong Senate · R-OK | Purchase | BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium) | $1,001 to $15k | Mar 30, 2026 | 113 days after the trade |
| Lisa C. McClain House · R-MI | Sale | BUD Anheuser-Busch Inbev SA Sponsored ADR | $1,001 to $15k | Aug 4, 2025 | 39 days after the trade |
| Lisa C. McClain House · R-MI | Partial sale | BUD Anheuser-Busch Inbev SA Sponsored ADR | $1,001 to $15k | Jun 11, 2025 | 63 days after the trade |
| Lisa C. McClain House · R-MI | Purchase | BUD Anheuser-Busch Inbev SA Sponsored ADR | $1,001 to $15k | Jun 9, 2025 | 65 days after the trade |
| Lisa C. McClain House · R-MI | Purchase | BUD Anheuser-Busch Inbev SA Sponsored ADR | $1,001 to $15k | Jul 16, 2025 | 28 days after the trade |
| Bruce Westerman House · R-AR | Sale | BUD Anheuser-Busch Inbev SA Sponsored ADR | $1,001 to $15k | Apr 21, 2025 | 21 days after the trade |
| Bruce Westerman House · R-AR | Purchase | BUD Anheuser-Busch Inbev SA Sponsored ADR | $1,001 to $15k | Mar 4, 2025 | 43 days after the trade |
Transactions
The last 0 rows filed, every code.
No transactions on file.
Insiders
Everyone who has filed a Form 4 here.
None yet.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.